Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario

BACKGROUND: Currently biomarkers play an essential role in diagnosis, treatment, and management of cancer. In non-small cell lung cancer (NSCLC) determination of biomarkers such as ALK, EGFR, ROS1 or PD-L1 is mandatory for an adequate treatment decision. The aim of this study is to determine the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadal, Ernest, Bautista, Dolores, Cabezón-Gutiérrez, Luis, Ortega, Ana Laura, Torres, Héctor, Carcedo, David, Ruiz de Alda, Lucía, Garcia, J. Francisco, Vieitez, Paula, Rojo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194132/
https://www.ncbi.nlm.nih.gov/pubmed/34112097
http://dx.doi.org/10.1186/s12885-021-08407-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194132/
https://www.ncbi.nlm.nih.gov/pubmed/34112097
http://dx.doi.org/10.1186/s12885-021-08407-1

Ejemplares similares